Use of the oral desogestrel compared with placebo for preoperative treatment of endometrioma in the patient who underwent to surgery in next 3 months The result will be evaluated on cyst diameter, the associated pain and side effect of the oral desogestrel.
Use of the oral desogestrel compared with placebo for preoperative treatment of endometrioma in the patient who underwent to surgery in next 3 months in Rajvithi hospital Patient will randomized in 2 group : Desogestrel and placebo After 1 months and 3 months the patient have to come to hospital to evaluate the result of study The result will be evaluated on cyst diameter, the associated pain and side effect of the oral desogestrel.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
20
Cerazette is the brand name of the desogestrel which contain of 0.075 mg of desogestrel
Rajavithi Hospital
Bangkok, Thailand
Cyst diameter
Cyst diameter is calculated by transvaginal ultrasound with calculated in the diameter of endometrimas (cm)
Time frame: 3 months after drug given
Associated pain
Associated pain is measured by the visual analog score. The patients will record the score on the book everytimes when they have pain
Time frame: 3 months after drug given
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.